These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 20429262)

  • 1. [Mortality characteristics in people with systemic lupus erythematosus].
    Mayer M
    Reumatizam; 2009; 56(2):44-9. PubMed ID: 20429262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cardiovascular risk factors in systemic lupus erythematosus and in antiphospholipid syndrome].
    Sarzi-Puttini P; Atzeni F; Carrabba M
    Minerva Med; 2003 Apr; 94(2):63-70. PubMed ID: 12858154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality in Malaysians with systemic lupus erythematosus.
    Paton NI; Cheong I; Kong NC; Segasothy M
    Med J Malaysia; 1996 Dec; 51(4):437-41. PubMed ID: 10968030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surviving the butterfly and the wolf: mortality trends in systemic lupus erythematosus.
    Borchers AT; Keen CL; Shoenfeld Y; Gershwin ME
    Autoimmun Rev; 2004 Aug; 3(6):423-53. PubMed ID: 15351310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality risks associated with specific clinical manifestations of systemic lupus erythematosus.
    Ward MM; Pyun E; Studenski S
    Arch Intern Med; 1996 Jun; 156(12):1337-44. PubMed ID: 8651844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus.
    Bruce IN
    Rheumatology (Oxford); 2005 Dec; 44(12):1492-502. PubMed ID: 16234277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular disease a hazard despite improved prognosis in patients with systemic lupus erythematosus: results from a Swedish population based study 1964-95.
    Björnådal L; Yin L; Granath F; Klareskog L; Ekbom A
    J Rheumatol; 2004 Apr; 31(4):713-9. PubMed ID: 15088296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death.
    Abu-Shakra M; Urowitz MB; Gladman DD; Gough J
    J Rheumatol; 1995 Jul; 22(7):1259-64. PubMed ID: 7562755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term prognosis and causes of death in systemic lupus erythematosus.
    Doria A; Iaccarino L; Ghirardello A; Zampieri S; Arienti S; Sarzi-Puttini P; Atzeni F; Piccoli A; Todesco S
    Am J Med; 2006 Aug; 119(8):700-6. PubMed ID: 16887417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic lupus erythematosus, atherosclerosis, and autoantibodies.
    Zampieri S; Iaccarino L; Ghirardello A; Tarricone E; Arienti S; Sarzi-Puttini P; Gambari P; Doria A
    Ann N Y Acad Sci; 2005 Jun; 1051():351-61. PubMed ID: 16126977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hospital experience and mortality in patients with systemic lupus erythematosus: which patients benefit most from treatment at highly experienced hospitals?
    Ward MM
    J Rheumatol; 2002 Jun; 29(6):1198-206. PubMed ID: 12064835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease activity, damage and survival in Mexican patients with acute severe systemic lupus erythematosus.
    Zonana-Nacach A; Yañez P; Jiménez-Balderas FJ; Camargo-Coronel A
    Lupus; 2007; 16(12):997-1000. PubMed ID: 18042596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Euro-lupus project: epidemiology of systemic lupus erythematosus in Europe.
    Cervera R; Khamashta MA; Hughes GR
    Lupus; 2009 Sep; 18(10):869-74. PubMed ID: 19671784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can morbidity and mortality of SLE be improved?
    Bongu A; Chang E; Ramsey-Goldman R
    Best Pract Res Clin Rheumatol; 2002 Apr; 16(2):313-32. PubMed ID: 12041956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients.
    Cervera R; Khamashta MA; Font J; Sebastiani GD; Gil A; Lavilla P; Mejía JC; Aydintug AO; Chwalinska-Sadowska H; de Ramón E; Fernández-Nebro A; Galeazzi M; Valen M; Mathieu A; Houssiau F; Caro N; Alba P; Ramos-Casals M; Ingelmo M; Hughes GR;
    Medicine (Baltimore); 2003 Sep; 82(5):299-308. PubMed ID: 14530779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival analysis and prognostic indicators of systemic lupus erythematosus in Pakistani patients.
    Rabbani MA; Habib HB; Islam M; Ahmad B; Majid S; Saeed W; Shah SM; Ahmad A
    Lupus; 2009 Aug; 18(9):848-55. PubMed ID: 19578112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence studies of systemic lupus erythematosus in Southern Sweden: increasing age, decreasing frequency of renal manifestations and good prognosis.
    Ståhl-Hallengren C; Jönsen A; Nived O; Sturfelt G
    J Rheumatol; 2000 Mar; 27(3):685-91. PubMed ID: 10743809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current causes of death in systemic lupus erythematosus in Europe, 2000--2004: relation to disease activity and damage accrual.
    Nossent J; Cikes N; Kiss E; Marchesoni A; Nassonova V; Mosca M; Olesinska M; Pokorny G; Rozman B; Schneider M; Vlachoyiannopoulos PG; Swaak A
    Lupus; 2007; 16(5):309-17. PubMed ID: 17576731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of short term mortality in systemic lupus erythematosus with time dependent measures of disease activity.
    Cook RJ; Gladman DD; Pericak D; Urowitz MB
    J Rheumatol; 2000 Aug; 27(8):1892-5. PubMed ID: 10955329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality studies in systemic lupus erythematosus. Results from a single center. II. Predictor variables for mortality.
    Abu-Shakra M; Urowitz MB; Gladman DD; Gough J
    J Rheumatol; 1995 Jul; 22(7):1265-70. PubMed ID: 7562756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.